Metallo-β-lactamases (MBLs) are powerful enzymes capable of conferring pathogenic bacteria with effective resistance against all major classes of β-lactam antibiotics. Their continuing global dissemination, paired with a lack of therapeutic inhibitors, has combined to pose a significant threat to human health. This thesis aims to use an evolutionary perspective to better understand the structure, function, and behaviour of the MBLs. The comprehensive characterization of eight MBLs in three different host organisms, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, revealed that host specific constraints can limit the effective periplasmic expression of the enzymes, and as a result, might restrict the dissemination of MBLs...
β-lactamases are enzymes capable of conferring pathogens with resistance against β-lactam antibiotic...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
Metallo-β-lactamases (MBLs) are powerful enzymes conferring antibiotic resistance to various pathoge...
Metallo-β-lactamases (MBLs) are powerful enzymes conferring antibiotic resistance to various pathoge...
Metallo-β-lactamases (MBLs) with activity towards a broad-spectrum of β-lactam antibiotics have beco...
Metallo-β-lactamases (MBLs) with activity towards a broad-spectrum of β-lactam antibiotics have beco...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The emergence of multidrug-resistant (MDR) Gram-negative pathogens and lack of new antibiotics in th...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
Enzymes known as metallo-β-lactamases (MBLs) are a major source of bacterial resistance against β-la...
β-lactamases are enzymes capable of conferring pathogens with resistance against β-lactam antibiotic...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
Metallo-β-lactamases (MBLs) are powerful enzymes conferring antibiotic resistance to various pathoge...
Metallo-β-lactamases (MBLs) are powerful enzymes conferring antibiotic resistance to various pathoge...
Metallo-β-lactamases (MBLs) with activity towards a broad-spectrum of β-lactam antibiotics have beco...
Metallo-β-lactamases (MBLs) with activity towards a broad-spectrum of β-lactam antibiotics have beco...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The emergence of multidrug-resistant (MDR) Gram-negative pathogens and lack of new antibiotics in th...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The spread of antibiotic resistance is one major global problem for healthcare systems. One of the m...
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β...
Enzymes known as metallo-β-lactamases (MBLs) are a major source of bacterial resistance against β-la...
β-lactamases are enzymes capable of conferring pathogens with resistance against β-lactam antibiotic...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-negative b...